Page 104 - 南京医科大学自然版
P. 104

第46卷第10期
               ·1534 ·                           南 京    医 科 大 学 学         报                        2026年10月


              侧重有所不同,多参数联合应用能够更全面地刻画                            statistical analysis. Hu Hao,Chen Huanhuan,and Wu Feiyun
              活动期 TAO 泪腺的复杂病理特征(水肿、炎症浸润                         analyzed the data,critically revised important content of the
              及早期纤维化),从而提升活动性分期效能。更重                            manuscript,and provided funding support. Xu Xiaoxuan designed
              要的是,与既往单独扫描相比,SyMRI能够基于单次                         the study protocol,made critical revisions to the manuscript,
              扫描同时获取这些参数,缩短扫描时间的同时提升                            and provided overall guidance.
              不同参数图像之间的空间对应性。基于上述技术                             [参考文献]
              优势及更优的分期效能,笔者认为SyMRI在TAO患                         [1] Lanzolla G,Marinò M,Menconi F. Graves disease:latest
              者活动性评估方面具有潜在应用价值。此外,本研                                 understanding of pathogenesis and treatment options[J].
              究在甲状腺功能正常患者中进行的敏感性分析获                                  Nat Rev Endocrinol,2024,20(11):647-660
              得了与总体分析基本一致的结果,进一步支持了泪                            [2] Song Y,Li T,Tang W,et al. Application progress of mag⁃
              腺SyMRI参数评估TAO活动性的稳定性。                                  netic resonance imaging in thyroid associated ophthalmop⁃
                  本研究存在一定的局限性:第一,样本量相对                               athy[J]. Front Endocrinol,2025,16:1537957
                                                                [3] Hoang T D,Stocker D J,Chou E L,et al. 2022 update on
              较小,未来仍需要更大样本队列验证本研究结果;
                                                                     clinical management of Graves disease and thyroid eye
              第二,仅探讨了泪腺SyMRI在TAO活动性分期中的
                                                                     disease[J]. Endocrinol Metab Clin North Am,2022,51
              价值,未来可联合多结构(眼外肌、眶脂肪)、多序列
                                                                    (2):287-304
             (如弥散加权成像、水脂分离 Dixon 技术)及泪液生
                                                                [4] Bartalena L,Kahaly G J,Baldeschi L,et al. The 2021
              化分析进一步提升分期诊断效能;第三,受样本量                                 European Group on Graves’ orbitopathy(EUGOGO)
              限制,本研究未进一步校正甲状腺功能状态、吸烟                                 clinical practice guidelines for the medical management
              史及TRAb水平等潜在混杂因素。虽然相关临床指                                of Graves’orbitopathy[J]. Eur J Endocrinol,2021,185
              标组间差异均无统计学意义,且甲状腺功能正常患                                (4):G43-G67
              者的敏感性分析结果与总体分析基本一致,但上述                            [5] Eckstein A K,Finkenrath A,Heiligenhaus A,et al. Dry
              因素对研究结果的潜在影响仍需在未来大样本研                                  eye syndrome in thyroid ⁃ associated ophthalmopathy :
              究进一步验证。                                                lacrimal expression of TSH receptor suggests involvement
                  综上,SyMRI作为一种先进的影像学技术,在评                            of TSHR ⁃ specific autoantibodies[J]. Acta Ophthalmol
                                                                     Scand,2004,82(3 Pt 1):291-297
              估 TAO 活动性方面展现出良好的应用前景。基于
                                                                [6] Kishazi E,Dor M,Eperon S,et al. Differential profiling of
              SyMRI 的泪腺定量和半定量参数作为一种客观、无
                                                                     lacrimal cytokines in patients suffering from thyroid ⁃
              创的辅助影像学标志物,可用于识别活动期TAO患
                                                                     associated orbitopathy[J]. Sci Rep,2018,8(1):10792
              者,并为CAS处于临界值或难以完成临床评估的患
                                                                [7] Huang D P,Luo Q,Yang H S,et al. Changes of lacrimal
              者提供补充信息。
                                                                     gland and tear inflammatory cytokines in thyroid⁃associated
                  利益冲突声明:                                            ophthalmopathy[J]. Invest Ophthalmol Vis Sci,2014,55
                  所有作者声明不存在利益冲突。
                                                                    (8):4935-4943
                  Conflict of Interests:                        [8] Gagliardo C,Radellini S,Morreale Bubella R,et al. Lacri⁃
                  All authors declare no competing interests.        mal gland herniation in Graves ophthalmopathy:a simple
                  作者贡献声明:                                            and useful MRI biomarker of disease activity[J]. Eur
                  刘广华负责整理分析数据,撰写初稿;周江参与构思研                           Radiol,2020,30(4):2138-2141
              究方案,对稿件重要内容进行修改;万颖、高文霞负责收集数                       [9] Zhang H Y,Lu T,Liu Y T,et al. Application of quantita⁃
              据,参与影像学评估及统计分析;胡昊、陈欢欢、吴飞云分析                            tive MRI in thyroid eye disease:imaging techniques and
              数据,对稿件重要内容进行修改,提供基金支持;许晓泉设计                            clinical practices[J]. J Magn Reson Imaging,2024,60
              本研究的方案,对稿件进行关键性修改,提供总体指导。                             (3):827-847
                  Authors’s Contributions:                      [10]Zhang Z X,Li S J,Wang W J,et al. Synthetic MRI for the
                  Liu Guanghua was responsible for data collation and analy⁃  quantitative and morphologic assessment of head and
              sis,drafting the initial manuscript. Zhou Jiang participated in  neck tumors:a preliminary study[J]. Dentomaxillofac
              conceptualizing the study design and critically revising impor⁃  Radiol,2023,52(6):20230103
              tant content of the manuscript. Wan Ying and Gao Wenxia  [11]Ji S,Yang D J,Lee J,et al. Synthetic MRI:technologies
              collected the data and contributed to imaging assessment and  and applications in neuroradiology[J]. J Magn Reson
   99   100   101   102   103   104   105   106   107   108   109